ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Phase II Study of Sorafenib and Docetaxel in Metastatic Prostate Cancer (GAO1)

This study is currently recruiting participants.
Study NCT00619996.   Last updated on May 27, 2008.   Information provided by Italian Trial in Medical Oncology

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:
1 Conditions listed in this trial
Prostate Cancer
2 Additional conditions recognized in this trial
Prostatic Neoplasms
3 More general conditions related to this trial
Genital Diseases, Male
Genital Neoplasms, Male
Neoplasms
Neoplasms by Site
Prostatic Diseases
Urogenital Neoplasms
4 Interventions listed in this trial
Sorafenib (Nexavar) and Docetaxel
5 Additional drug interventions recognized in this trial
Docetaxel
Sorafenib
6 More general drug interventions related to this trial
Antineoplastic Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Protein Kinase Inhibitors
Therapeutic Uses
7 Sponsors listed in this trial
Italian Trial in Medical Oncology




Links to all studies - primarily for crawlers